Chineseinvestors.com Inc. (fka CIIX)

[NetworkNewsWire]

CIIX OptHemp Line Achieves a Big Hit with Product Launch

- OptHemp Product Line successfully launched on Amazon and Alibaba
- CBD Magic Hemp Series generated 40,000 views and the purchase of over 91 units just minutes into launch
- CIIX offering is an innovative product line in what CBD Biotechnology believes to be an untapped segment of China’s booming skin care market

ChineseInvestors.com, Inc. (OTCQB: CIIX), in partnership with its foreign enterprise, CBD Biotechnology Co. Ltd. and through its subsidiary ChineseHempOil.com, Inc. has successfully launched its OptHemp product Line via a Top 100 platinum level seller on Amazon.com (NASDAQ: AMZN) and on China’s largest e-commerce retailer Alibaba. During its debut broadcast of “China Taobao Live Broadcasting Celebrity Show,” the company’s “CBD Magic Hemp Series” generated 40,000 views and the purchase of over 91 units just minutes into launch. ChineseInvestors.com CEO Warren Wang indicated in the news release that the product line’s successful initial launch on Taobao “solidifies our belief that Chinese consumers recognize that the anti-inflammatory agents and anti-oxidants contained in hemp-extract can have positive effects on the skin.”

According to Markets Insider (http://nnw.fm/yJ14b), the CBD Magic Hemp Series is the company’s first line of hemp-infused skin care products (the CBDBIO TECH Brightening and Refreshing Moisturizer, CBDBIO TECH Perfecting Shield Primer and CBDBIO TECH Peptide Collagen Solution). The products are intended to bring a moisturizing balance, form a protective layer, provide an even skin tone, and firm the skin while reducing the signs of aging. Different from other skin care lines currently available in China, the products are infused with non-industrial cannabidiol or CBD. While CBD, known as a powerful antioxidant and anti-inflammatory agent, has been widely used in skin care products in western countries for some time, its groundbreaking use in CBD Magic Hemp Series positions the innovative product line in what CBD Biotechnology believes to be an untapped segment of China’s skin care industry.

This product launch and debut with CBD products positions CIIX as an emerging leader in a strong market segment. According to CBD Biotechnology and as reported by Fidelity Investments (http://nnw.fm/kOh7m): “China has one of the world’s largest consumer markets for skin care products. Retail sales of skincare products and make-up products in China reached 169.1 billion yuan and 28.3 billion yuan respectively in 2016, with year-over-year growth of 5% and 12% respectively. Skin care is expected to reach 223.3 billion yuan in 2021 with growth driven by rising awareness of skin health and consumption upgrading Chinese consumers. As one of the first hemp infused skin care brands in China, we are confident that CBD Biotechnology will lead Chinese market, with potential for global expansion.”

For more information, visit the company’s website at www.ChineseInvestors.com